About AtaCor Medical
AtaCor Medical is a company based in San Clemente (United States) founded in 2014 by Alan Marcovecchio, Rick Sanghera, and Sean McGeehan.. AtaCor Medical has raised $136.8 million across 4 funding rounds from investors including Longview Partners, Broadview Ventures and aMoon. The company has 15 employees as of December 31, 2022. AtaCor Medical offers products and services including EV Temporary Pacing Lead System and EV-ICD Lead System. AtaCor Medical operates in a competitive market with competitors including AtriCure, CardioFocus, Kestra Medical Technologies, EBR Systems and AuriGen Medical, among others.
- Headquarter San Clemente, United States
- Employees 15 as on 31 Dec, 2022
- Founders Alan Marcovecchio, Rick Sanghera, Sean McGeehan
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Atacor Medical, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$136.8 M (USD)
in 4 rounds
-
Latest Funding Round
$75 M (USD), Series D
Oct 06, 2025
-
Investors
Longview Partners
& 6 more
-
Employee Count
15
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AtaCor Medical
AtaCor Medical offers a comprehensive portfolio of products and services, including EV Temporary Pacing Lead System and EV-ICD Lead System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides temporary pacing without entering the heart or vascular system.
Delivers defibrillation and ATP without transvenous leads for safety.
Unlock access to complete
Unlock access to complete
Funding Insights of AtaCor Medical
AtaCor Medical has successfully raised a total of $136.8M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $75 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series D — $75.0M
-
First Round
First Round
(18 Sep 2018)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Series D - AtaCor Medical | Valuation |
investors |
|
| Apr, 2024 | Amount | Series C - AtaCor Medical | Valuation | Arboretum Ventures | |
| Apr, 2020 | Amount | Series B - AtaCor Medical | Valuation | Longview Partners , Hatteras Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AtaCor Medical
AtaCor Medical has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Longview Partners, Broadview Ventures and aMoon. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed-stage life sciences investments are made in the US.
|
Founded Year | Domain | Location | |
|
Venture capital investments in healthcare are focused on by aMoon.
|
Founded Year | Domain | Location | |
|
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AtaCor Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AtaCor Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Atacor Medical Comparisons
Competitors of AtaCor Medical
AtaCor Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtriCure, CardioFocus, Kestra Medical Technologies, EBR Systems and AuriGen Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
|
|
| domain | founded_year | HQ Location |
Endoscopic catheter for atrial fibrillation ablation is developed.
|
|
| domain | founded_year | HQ Location |
Medical devices are developed to support cardiovascular patients at risk.
|
|
| domain | founded_year | HQ Location |
Wireless cardiac pacing devices are developed for left ventricle stimulation.
|
|
| domain | founded_year | HQ Location |
Trans-septal implants for atrial fibrillation treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Atacor Medical
Frequently Asked Questions about AtaCor Medical
When was AtaCor Medical founded?
AtaCor Medical was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Where is AtaCor Medical located?
AtaCor Medical is headquartered in San Clemente, United States. It is registered at San Clemente, California, United States.
Who is the current CEO of AtaCor Medical?
Rick Sanghera is the current CEO of AtaCor Medical. They have also founded this company.
Is AtaCor Medical a funded company?
AtaCor Medical is a funded company, having raised a total of $136.8M across 4 funding rounds to date. The company's 1st funding round was a Series B of $25M, raised on Sep 18, 2018.
How many employees does AtaCor Medical have?
As of Dec 31, 2022, the latest employee count at AtaCor Medical is 15.
What does AtaCor Medical do?
Founded in 2014 and based in San Clemente, United States, AtaCor Medical operates in the medical device sector. An implantable pacemaker system is being developed, with the lead positioned in tissue above the heart to deliver pacing therapy. No leads or hardware are required inside or on the heart. Ventricular pacing or AV synchronous nodal therapy is enabled through this approach.
Who are the top competitors of AtaCor Medical?
AtaCor Medical's top competitors include AtriCure, CardioFocus and Kestra Medical Technologies.
What products or services does AtaCor Medical offer?
AtaCor Medical offers EV Temporary Pacing Lead System and EV-ICD Lead System.
Who are AtaCor Medical's investors?
AtaCor Medical has 7 investors. Key investors include Longview Partners, Broadview Ventures, aMoon, Hatteras Venture Partners, and CHV.